ScripsAmerica, Inc. engages in the distribution of generic and over-the-counter (OTC) drugs to hospitals, nursing homes, government agencies, and retail. The company is headquartered in Clifton, New Jersey. The company went IPO on 2012-05-30. The firm's subsidiaries include Main Avenue Pharmacy Inc. (Main Avenue), DispenseDoc Inc. (DispenseDoc) and Pharmacy Administration, Inc. (Pharmacy Administration). The company also holds interests in P.I.M.D. International LLC (PIMD). Its operations consist of the sale and compounding of non-sterile topical and transdermal pain creams through Main Avenue; wholesale sales to independent pharmacies and other medical providers through PIMD; pharmacy dispensing services for individual doctors through DispenseDoc, and billing and administrative services through Pharmacy Administration. Main Avenue's prescription pain creams incorporate approximately eight active pharmaceutical ingredients for application on the skin and in localized areas. As of December 31, 2014, PIMD held licenses in over 20 states to receive, store and ship Schedule 3 through Schedule 5 formulary pharmaceuticals.
Follow-Up Questions
ScripsAmerica Inc (SCRCQ)의 PER은 얼마입니까?
ScripsAmerica Inc의 PER은 0입니다
ScripsAmerica Inc의 CEO는 누구입니까?
Mr. Brian Ettinger은 2011부터 회사에 합류한 ScripsAmerica Inc의 Chairman of the Board입니다.
SCRCQ 주식의 가격 성능은 어떻습니까?
SCRCQ의 현재 가격은 $0이며, 전 거래일에 decreased 0% 하였습니다.
ScripsAmerica Inc의 주요 사업 주제나 업종은 무엇입니까?
ScripsAmerica Inc은 Retail 업종에 속하며, 해당 부문은 Consumer Staples입니다
